Strategic Rationale Valeant (now Bausch Health) has a history of transformational acquisitions, including Bausch + Lomb, indicating ongoing growth and integration activities that may drive demand for enterprise systems, manufacturing optimization, and regulatory/compliance solutions.

Regulatory & Compliance Past investigations and legal scrutiny around pricing and kickbacks suggest a need for robust compliance programs, internal audit, and anti-corruption controls. This presents opportunities for risk management, governance, and ERP system enhancements.

Financial Health With revenue in the multi-billion range, there is potential for high-value technology and services engagements spanning ERP optimization, data analytics, and supply chain modernization to support scale and efficiency.

Technology Footprint Existing tech stack includes SharePoint, Salesforce, SAP, and Microsoft tools, indicating openness to enterprise-grade digital transformation, integration projects, and cloud-based collaboration that can be upsold with data integration and workflow automation.

Growth & Acquisitions Historical acquisitions and product expansions (e.g., Addyi launch and AcneFree acquisition) point to a growth-oriented organization that may seek partnerships for go-to-market optimization, regulatory labeling, and regional market expansion.